Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.795 USD | -1.58% | +4.28% | +12.20% |
05-02 | Transcript : Arbutus Biopharma Corporation, Q1 2024 Earnings Call, May 02, 2024 | |
05-02 | Earnings Flash (ABUS) ARBUTUS BIOPHARMA CORPORATION Posts Q1 Revenue $1.5M | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.20% | 536M | |
-2.35% | 89.33B | |
+3.29% | 41.19B | |
-15.17% | 31.87B | |
+53.23% | 24.52B | |
-13.96% | 15.68B | |
-8.63% | 12.34B | |
-39.65% | 12.23B | |
+6.22% | 8.83B | |
-6.43% | 8.28B |
- Stock Market
- Equities
- ABUS Stock
- News Arbutus Biopharma Corporation
- Arbutus Biopharma Promotes Dr. Karen Sims to Chief Medical Officer, Hires Christopher Naftzger as Chief Compliance Officer